Business Description
PT Bundamedik Tbk
ISIN : ID1000161201
Description
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.28 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.94 | |||||
| Debt-to-EBITDA | 6.41 | |||||
| Interest Coverage | 1.89 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.61 | |||||
| Beneish M-Score | -2.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9 | |||||
| 3-Year EBITDA Growth Rate | -6.3 | |||||
| 3-Year EPS without NRI Growth Rate | -59 | |||||
| 3-Year Book Growth Rate | 16.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 111.15 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 9.36 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.7 | |||||
| 9-Day RSI | 46.28 | |||||
| 14-Day RSI | 47.72 | |||||
| 3-1 Month Momentum % | -2.99 | |||||
| 6-1 Month Momentum % | -12.75 | |||||
| 12-1 Month Momentum % | -16.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.76 | |||||
| Quick Ratio | 1.7 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 19.72 | |||||
| Days Sales Outstanding | 29.27 | |||||
| Days Payable | 23.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.23 | |||||
| Dividend Payout Ratio | 0.44 | |||||
| Forward Dividend Yield % | 0.23 | |||||
| 5-Year Yield-on-Cost % | 0.23 | |||||
| Shareholder Yield % | -12.19 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.13 | |||||
| Operating Margin % | 6.69 | |||||
| Net Margin % | 1.98 | |||||
| FCF Margin % | -14.45 | |||||
| ROE % | 1.92 | |||||
| ROA % | 0.94 | |||||
| ROIC % | 1.76 | |||||
| 3-Year ROIIC % | -10.58 | |||||
| ROC (Joel Greenblatt) % | 4.16 | |||||
| ROCE % | 4.19 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 189.6 | |||||
| Forward PE Ratio | 32.21 | |||||
| PE Ratio without NRI | 196.67 | |||||
| PEG Ratio | 9.5 | |||||
| PS Ratio | 1.38 | |||||
| PB Ratio | 1.34 | |||||
| Price-to-Tangible-Book | 1.42 | |||||
| Price-to-Operating-Cash-Flow | 34.79 | |||||
| EV-to-EBIT | 34.4 | |||||
| EV-to-EBITDA | 16.16 | |||||
| EV-to-Forward-EBITDA | 11.7 | |||||
| EV-to-Revenue | 2.44 | |||||
| EV-to-Forward-Revenue | 1.85 | |||||
| EV-to-FCF | -16.86 | |||||
| Price-to-GF-Value | 0.67 | |||||
| Price-to-Peter-Lynch-Fair-Value | 16.6 | |||||
| Price-to-Graham-Number | 3.52 | |||||
| Earnings Yield (Greenblatt) % | 2.91 | |||||
| FCF Yield % | -10.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PT Bundamedik Tbk Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil Rp) | 1,546,344.765 | ||
| EPS (TTM) (Rp) | 1.308 | ||
| Beta | 0.03 | ||
| 3-Year Sharpe Ratio | -1.8 | ||
| 3-Year Sortino Ratio | -1.75 | ||
| Volatility % | 21.35 | ||
| 14-Day RSI | 47.72 | ||
| 14-Day ATR (Rp) | 14.118721 | ||
| 20-Day SMA (Rp) | 248.3 | ||
| 12-1 Month Momentum % | -16.67 | ||
| 52-Week Range (Rp) | 228 - 376 | ||
| Shares Outstanding (Mil) | 8,603.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PT Bundamedik Tbk Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PT Bundamedik Tbk Stock Events
| Event | Date | Price (Rp) | ||
|---|---|---|---|---|
| No Event Data | ||||
PT Bundamedik Tbk Frequently Asked Questions
What is PT Bundamedik Tbk(ISX:BMHS)'s stock price today?
The current price of ISX:BMHS is Rp248.00. The 52 week high of ISX:BMHS is Rp376.00 and 52 week low is Rp228.00.
When is next earnings date of PT Bundamedik Tbk(ISX:BMHS)?
The next earnings date of PT Bundamedik Tbk(ISX:BMHS) is .
Does PT Bundamedik Tbk(ISX:BMHS) pay dividends? If so, how much?
The Dividend Yield %  of PT Bundamedik Tbk(ISX:BMHS) is 0.23% (As of Today), Highest Dividend Payout Ratio of PT Bundamedik Tbk(ISX:BMHS) was 2.08. The lowest was 0.26. And the median was 1.17. The  Forward Dividend Yield % of PT Bundamedik Tbk(ISX:BMHS) is 0.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers